Picture of CorMedix logo

CRMD — CorMedix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: CorMedix Believes It Has Sufficient Cash, Cash Equivalents And Available Resources To Fund Commercial Launch Of DefenCath

Jan 8 (Reuters) - CorMedix Inc  CRMD.O :
    * CORMEDIX INC: BELIEVES IT HAS SUFFICIENT CASH, CASH
EQUIVALENTS
AND AVAILABLE RESOURCES TO FUND COMMERCIAL LAUNCH OF DEFENCATH
    * CORMEDIX INC: ESTIMATES TIMING FOR DEFENCATH COMMERCIAL
AVAILABILITY AT APRIL 15, 2024 FOR INPATIENT SETTING
    * CORMEDIX INC: ESTIMATES TIMING FOR DEFENCATH COMMERCIAL
AVAILABILITY AT NO SOONER THAN JULY 1, 2024 FOR OUTPATIENT
SETTING
    * CORMEDIX INC- BELIEVES IT HAS SUFFICIENT CASH, CASH
EQUIVALENTS
AND AVAILABLE RESOURCES TO FUND COMMERCIAL LAUNCH

Source text for Eikon:  ID:nGNXbtfRBV 
Further company coverage:  CRMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CorMedix

See all news